Showing results (2101-2110 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|December 31, 2024
Value-Based Indication-Specific Pricing and Weighted-Average Pricing: Estimated Price and Cost Savings for Cancer DrugsDaniel Tobias Michaeli, Thomas MichaeliPharmacoeconomics|March 6, 2025
Economic Evaluation of Interventions to Reduce Antimicrobial Resistance: A Systematic Literature Review of MethodsKristina Aluzaite, Marta O Soares, Catherine Hewitt, et al.Pharmacoeconomics|November 15, 2024
Unravelling the Association Between Uncertainties in Model-based Economic Analysis and Funding Recommendations of Medicines in AustraliaQunfei Chen, Martin Hoyle, Varinder Jeet, et al.Pharmacoeconomics|November 9, 2024
The Use of Real-World Data for Estimating Relative Treatment Effects in NICE Health Technology Assessment Submissions: A ReviewYoojung Che, Stephen Duffield, Manuel GomesPharmacoeconomics|October 15, 2024
Design and Features of Pricing and Payment Schemes for Health Technologies: A Scoping Review and a Proposal for a Flexible Need-Driven ClassificationVittoria Ardito, Oriana Ciani, Michael DrummondPharmacoeconomics|September 26, 2024
Comparative Analysis of Traditional and Pharmacometric-Based Pharmacoeconomic Modeling in the Cost-Utility Evaluation of Sunitinib TherapyMaddalena Centanni, Janine Nijhuis, Mats O Karlsson, et al.Pharmacoeconomics|October 25, 2024
Estimating the Incremental Cost Per QALY Produced by the Spanish NHS: A Fixed-Effect Econometric ApproachLaura Vallejo-TorresPharmacoeconomics|February 17, 2025
A Taxonomy for Assessing Whether HRQoL Value Sets Are ObsoleteRichard Norman, Bram Roudijk, Marcel Jonker, et al.Pharmacoeconomics|February 20, 2025
Cost-Effectiveness Analysis of Nirsevimab for Preventing Respiratory Syncytial Virus-Related Lower Respiratory Tract Disease in Dutch Infants: An Analysis Including All-Infant ProtectionFlorian Zeevat, Simon van der Pol, Alexia Kieffer, et al.Pharmacoeconomics|June 20, 2024
Rapid Assessment of the Need for Evidence: Applying the Principles of Value of Information to Research PrioritisationDavid Glynn, Vijay S Gc, Karl Claxton, et al.Pageof 336